Navigation Links
Monoclonal antibody reduces exacerbations in asthmatics

Patients with symptomatic moderate asthma who were treated with anti-tumor necrosis factor alpha, an anti-inflammatory monoclonal antibody, experienced significantly fewer disease exacerbations than individuals taking a placebo.

This research appears in the first issue for October 2006 of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society.

Trevor T. Hansel, M.D., Ph.D., of the National Heart and Lung Institute at Royal Brompton Hospital in London, and 11 associates infused 14 patients with infliximab, a monoclonal antibody that binds and neutralizes tumor necrosis factor alpha (TNFá). Eighteen patients received placebo during the eight-week double-blind study.

According to the investigators, both structured and inflammatory cells in asthmatics can release TNFá, which is an intercellular messenger protein, a cytokine, produced by white blood cells.

"Anti-TNFá therapy has been shown to be effective in patients with rheumatoid arthritis, ankylosing spondylitis, Crohn's disease and psoriasis, but ineffective in patients with chronic obstructive pulmonary disease (COPD)," said Dr. Hansel. "Preliminary reports of efficacy in asthma patients with concomitant rheumatoid arthritis have been encouraging. Small prospective studies of a soluble receptor directed against TNFá in severe refractory asthma have also shown improvements in lung function and airway hyperresponsiveness."

During the study, 13 of the 18 patients on placebo (72 percent) experienced exacerbations, as compared to only four out of 14 patients (29 percent) on infliximab therapy.

All patients in the study cohort continued to use inhaled corticosteroids for their asthma. Study protocol required them to be symptomatic during a two- to four-week run-in period.

After the run-in phase, infusions of either infliximab or placebo were administered at weeks zero, two and six.

"Treatment with inflixima
'"/>

Source:American Thoracic Society


Page: 1 2

Related biology news :

1. Secrets to antibodys success against West Nile Virus surprise scientists
2. New antibody shows promise as cure for anthrax
3. Computer models aid understanding of antibody-dependent enhancement in spread of dengue fever
4. High resolution snapshots detail dynamics of a cocaine antibody
5. Buckyballs boost antibodys chemotherapy payload
6. Combination therapy with a monocloncal antibody and a vaccine leads to tumor rejection
7. A single sugar found responsible for an antibodys ability to treat inflammation
8. A key antibody, IgG, links cells capture and disposal of germs
9. Male circumcision reduces risk of HIV transmission from women to men
10. Deficiency of growth hormone and IGF-1 reduces cancer and kidney disease, but creates other problems
11. New miniaturised chip dramatically reduces time taken for DNA analysis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Monoclonal antibody reduces exacerbations asthmatics

(Date:5/21/2013)... method for delivering molecules into single, targeted cells ... technique could find applications in drug delivery, cell ... a technique used to deliver molecules into ... that are caused by exposing them to electric ... cell transfection. (Cell transfection is the introduction of ...
(Date:5/21/2013)... in shape is an uphill battle? Try staying fit ... weightlessness withers muscle and bone. , That,s the challenge ... with a new three-year, $1.2 million grant from NASA. ... during multiyear exploratory missions. , "You could give astronauts ... can,t get them to stick to it, it isn,t ...
(Date:5/21/2013)... ANDOVER, Mass. , May 21, 2013 ... that CX50 xMATRIX, the world,s first portable ultrasound with ... Intracardiac Echo (ICE) capability. The CX50 xMATRIX with available ... Paris at the EuroPCR, official ... (EAPCI), May 21-24. Since its launch in ...
Breaking Biology News(10 mins):Single-cell transfection tool enables added control for biological studies 2Fueling fitness on the final frontier 2Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2
... in the intensive care unit (ICU) previously occupied ... the odds of acquiring such bacteria, according to ... Archives of Internal Medicine, one of the JAMA/Archives ... and death in hospitals: methicillin-resistant Staphylococcus aureus (MRSA) ...
... Children's Hospital Boston have demonstrated that it may be ... and protect the heart from scarring. Working with rats, ... of cell division with a naturally occurring growth factor ... agents enabled heart-muscle cells to multiply and the heart ...
... environmentally safe compounds like sugars and vitamin C, ... a popular technology used to generate a diverse ... targeted drug delivery systems to resilient paint coatings. ... polymerization (ATRP) now enables large-scale production of many ...
Cached Biology News:Transmission of antibiotic-resistant bacteria linked to previous intensive care unit room occupants 2Rescuing injured hearts by enhancing regeneration 2Rescuing injured hearts by enhancing regeneration 3Carnegie Mellon scientists use 'green' approach to transform plastics manufacturing 2Carnegie Mellon scientists use 'green' approach to transform plastics manufacturing 3
(Date:5/22/2013)... BUFFALO, N.Y. , May 22, 2013 /PRNewswire/ ... exclusive license for a patent pending novel genomic ... a molecular diagnostic test that could help in ... (NEPC) prostate cancer.  Neuroendocrine prostate ... adenocarcinoma (PCA) that can arise de novo, but ...
(Date:5/22/2013)... 2013 AudioNotch is ... tinnitus treatment. AudioNotch is pleased to announce a ... locations in both British Columbia and Alberta, Destination ... hearing services. AudioNotch's tinnitus treatment program is now ... a Destination Hearing clinic, patients have the detection ...
(Date:5/22/2013)... 2013 A recent study from researchers ... to find that those who took probiotics were able to ... the study showed that in extreme heat conditions, probiotics were ... adult acne treatment explains what this new discovery ... help their skin condition. , While researchers tote the ...
(Date:5/21/2013)... , May 21, 2013  The Lindsley F. Kimball ... that it is a Grand Challenges Explorations winner, ... Foundation .  Dr. Sara Lustigman , Head ... global health and development research project, titled Innovative 3-D ...  These worms are needed to screen drugs to help eliminate ...
Breaking Biology Technology:Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer 2AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 3
... Vaccinex, Inc. announced today,the award of a key ... discovery technology platform, branded as ActivMab(R) Technology.,Vaccinex is ... new,monoclonal antibody therapies, and has advanced four of ... "This European patent, and related patents already awarded ...
... Amylin Pharmaceuticals,Inc. (Nasdaq: AMLN ) will be presenting ... December 6, 2007 at 7:15 a.m. PT / 3:15 ... Executive Director of,European Operations, will be providing a corporate ... webcast, and a recording will be made,available following the ...
... Nov. 30 Cord Blood America, Inc.,(OTC Bulletin ... preservation,company ( http://www.cordblood-america.com ) focused on bringing the ... and internationally,announced today that it has completed a ... Notes, at an original,issue discount of 20%, in ...
Cached Biology Technology:Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program 2Cord Blood America Announces Financing 2Cord Blood America Announces Financing 3
... used to detect the appearance of AcNPV ... cells as early as 8-24 hours post-infection. ... Titer Kit, which allows determination of baculovirus ... The FastPlax Antibody can also be used ...
Alexa Fluor 647 anti-mouse IL-12 (Interleukin-12) / IL-23 (Interleukin-23) p40 25 ug...
PKC (pSer345), phospho-specific...
PE Rat anti-Hu CD267 Storage Temperature: Refrigerate(2 to 8C)...
Biology Products: